CHANGCHUN, China & LOS ANGELES--(BUSINESS WIRE)--China Yongxin Pharmaceuticals Inc. (OTCBB:CYXN), a leading manufacturer, distributor and retailer of pharmaceuticals in Northeastern China, today announced that it has retained Investor Relations International (“IRI”) to lead an expanded shareholder communication program.
